Microbiome Movement - Drug Development & Nutrition Asia Summit

Built in close collaboration with microbiome-focused researchers in Asia including the Japan Microbiome Consortium, Korea Society of Gut Microbiome, KoBioLabs, Shionogi Pharmaceuticals, Tokyo Institute of Technology and many more, the Microbiome Movement arrives in Asia for the first time to build on from the global success of events in the US and Europe, all dedicated to harnessing the power of the human microbiome to identify novel opportunities in therapeutic, biomarker and nutritional product development. Join the discussion amongst microbiome leaders in Asia including:

• Jonathan Krive, CEO, AsiaBiome
• Jae-Gu Pan, CTO, GenoFocus
• Jisoo Park, Founder and CEO, Genome and Company
• Suenie Park, Professor, Hallym University & Korea Society of Gut Microbiome
• Senior Representative, Japan Microbiome Consortium
• GwangPyo Ko, Founder and CEO, KoBioLabs
• Lee Yuan Kun, Associate Professor, National University of Singapore
• Shingo Arioka, Research Manager, Shionogi Pharmaceuticals
• Takuji Yamada, Associate Professor, Tokyo Institute of Technology
• Yoshiyuki Sakuraba, CEO, Varinos
• Yiming Yin, VP Research & Development, XBiome

As the research on the human microbiome and it’s applications to industry have become a truly global initiative, join the Microbiome Movement in Singapore and stay up to date with the latest developments and untapped opportunity in Asia. Visit the website to view the agenda, speakers and to register.


Jonathan Krive - Asia Biome, Ken Kasahara - Chitose Bio, Jae-Gu Pan - Genofocus, Jisoo Pae - Genome & Company, Yang Bo Gie - GI Innovation, Suenie Park - Hallym University, GwwangPyo Ko - KoBioLabs, Jon Sik Chun - Seoul National University, Shingo Arioka - Shionogi Pharmaceuticals, Yoshiyuki Sakuraba - Varinos, Takuji Yamada - Tokyo Institute of Technology, Yiming Yin - XBiome

Go to event website